TABLE 3.
Nuclear features |
Clinical characteristics of patients
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Primary tumor site
|
TNM stage
|
Regional response1
|
Regional recurrence
|
Distant metastases
|
New primary tumor
|
|||||||
PT | NM | PT | NM | PT | NM | PT | NM | PT | NM | PT | NM | |
Morphometric | + | + | + | + | ||||||||
Photometric | + | + | + | + | ||||||||
Discrete | + | + | + | + | + | |||||||
Markovian | + | + | ||||||||||
Non-Markovian | + | + | + | + | + | + | ||||||
Fractal | + | + | + | |||||||||
Run-length | + | + |
PT, Primary tumor; NM, Neck metastasis
At 8–12 weeks post-therapy